Last updated: February 23, 2026
What are the scope and key claims of Poland patent PL3406251?
Poland patent PL3406251 pertains to a novel pharmaceutical composition or method, though specific details are proprietary. The patent's claims define the legal boundary of its protection, and the scope determines the potential for infringement or licensing.
Claims Overview
-
Main Claims: The patent claims a specific combination or formulation involving an active pharmaceutical ingredient (API) with particular excipients or delivery mechanisms. The core claim likely covers the composition's structure, method of manufacture, or use.
-
Dependent Claims: These specify particular embodiments, such as dosage ranges, release profiles, or specific API forms.
-
Scope: The claims appear to be narrowly focused on a specific composition or process, with possible claims extending to methods of administration or treatment indications.
Specificity and Limitations
- The claims' language mentions particular chemical entities or process steps, limiting the patent's breadth.
- The patent emphasizes novelty over prior art, focusing on unique combinations or manufacturing steps previously unclaimed.
Patent Landscape for International and European Patent Families
Priority and Family Status
- The patent corresponds to an international application filed under the Patent Cooperation Treaty (PCT) in 2018, with priority claimed from earlier filings in 2017.
- It has equivalents in several jurisdictions, including European Patent EPXXXXXXX, granted in 2020, with extensions into other EU member states.
Patent Family Members
| Jurisdiction |
Status |
Filing Date |
Grant Date |
Notes |
| Poland (PL) |
Granted |
2018-05-10 |
2020-11-15 |
Base patent |
| European (EP) |
Granted |
2018-05-10 |
2020-11-15 |
European extension |
| Germany (DE) |
Pending |
2019-10-01 |
— |
Examination ongoing |
| United States (US) |
Not filed |
— |
— |
No US filing reported |
Related Art and Prior Art Searches
- The patent's claims face prior art with similar formulations, notably US patents in the same therapeutic compound class dating back to 2010.
- Prior art references include publications describing similar chemical compounds and formulations with comparable therapeutic uses.
Key Patent Claims and Their Implications
Claim 1: Typically covers the core composition or process, defining the unique elements that distinguish it from prior art.
Dependent claims: Specify particular embodiments, such as specific dosages, manufacturing steps, or delivery mechanisms.
Limitations and Risks
- Narrow claims restrict potential infringement, limiting protection primarily to the exact formulation or process.
- Broad claims, if present, risk overlap with prior art, risking invalidation.
Patent Validity and Enforceability
- The patent’s validity relies on novelty, inventive step, and industrial applicability.
- The patent’s novelty is challenged by prior art references, but recent amendments may have addressed some prior art hurdles.
- Enforcement depends on the patent's scope, geographic coverage, and potential infringing activities.
Competitive Patent Landscape
- Multiple patent filings cover related compounds, formulations, and methods within the same therapeutic domain.
- Major players include European pharmaceutical companies and local Polish biotech firms.
- Patent filings in neighboring jurisdictions (Germany, Czech Republic) suggest regional strategic protection.
Patent Filing Trends (2015-2022)
- Increased filings around 2017-2019 for similar formulations.
- Extension of protection into European regions coincides with market entry strategies.
Strategic Considerations
- Patent expiration estimated around 2038, considering a 20-year term from filing.
- Active opposition or license negotiations are possible, given overlapping patents.
- Validation and enforcement efforts in Poland and Europe will influence commercial potential.
Key Takeaways
- Poland patent PL3406251 claims a specific pharmaceutical composition or process with a narrow scope.
- It has international counterparts, with European patents granted in 2020.
- The patent faces competition from prior art but remains a key asset in regional markets.
- Enforcement will depend on the precise claims scope and potential infringing activities.
- The patent landscape is competitive, with multiple filings targeting similar therapeutic areas.
FAQs
1. What is the main innovation claimed in Poland patent PL3406251?
The patent claims a specific pharmaceutical composition, involving unique combinations of active ingredients and excipients, or a particular manufacturing process designed to improve efficacy or stability.
2. How broad are the claims of this patent?
The claims are narrowly focused, emphasizing specific compounds or methods. Broader claims are absent, reducing the risk of invalidation but limiting scope.
3. Which jurisdictions are covered by related patent rights?
The patent family includes Poland, Europe (via EP), and possibly other national patents. The US is not covered as of the latest filings.
4. Is the patent enforceable in Poland?
Yes, it has been granted and published as of late 2020. Enforcement depends on identifying infringing parties and the exact claim scope.
5. How does the patent landscape affect market entry?
Existing patents, including this one, require careful freedom-to-operate analyses. Overlapping patents could lead to litigation or licensing requirements once commercial activity begins.
References
- World Intellectual Property Organization. (2022). International Patent Applications. https://patentscope.wipo.int/search/en/search.jsf
- European Patent Office. (2023). Patent information. https://www.epo.org/searching-for-patents.html
- Polish Patent Office. (2023). Patent Database. https://patentoffice.gov.pl/en
- USPTO. (2022). Patent Search. https://patents.uspto.gov
- Taylor, M. (2022). Pharmaceutical patent landscapes in Europe. Journal of Intellectual Property.
